Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus

Hala Ahmadieh1 Faculty of Medicine, Clinical Sciences Department, Beirut Arab University

Nisrine Ghazal2 Department of Endocrinology and Metabolism, American University of Beirut, Beirut, Lebanon

Sami T Azar3 Department of Internal Medicine, Division of Endocrinology, American University of Beirut, New York, NY, USACorrespondence[email protected]

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Yinhui Li, Hui Li, Liming Dong, Dandan Lin, Lijuan Xu, Pengwei Lou, Deng Zang, Kai Wang & Li Ma. (2022) A Network Meta-Analysis of the Dose–Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes. Frontiers in Endocrinology 13.
Crossref

Annunziata Lapolla, Flavia Amaro, Daniela Bruttomesso, Paolo Di Bartolo, Giorgio Grassi, Claudio Maffeis, Francesco Purrello & Stefano Tumini. (2020) Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology and Pediatric Diabetoloy (SIEDP). Nutrition, Metabolism and Cardiovascular Diseases 30:10, pages 1633-1644.
Crossref

Yibing Wang, Yang Lou, Jiang Wang, Dan Li, Hui Chen, Tiannan Zheng, Chunmei Xia, Xiaohan Song, Tiancheng Dong, Jingya Li, Jia Li & Hong Liu. (2019) Design, synthesis and biological evaluation of 6-deoxy O-spiroketal C-arylglucosides as novel renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. European Journal of Medicinal Chemistry 180, pages 398-416.
Crossref

Yusuf OlgarBelma Turan. (2019) A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn 2+ -transporters in cardiomyocytes from insulin-resistant metabolic syndrome rats through inhibition of oxidative stress . Canadian Journal of Physiology and Pharmacology 97:6, pages 528-535.
Crossref

Karun Badwal, Tooba Tariq & Diane Peirce. (2018) Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Presenting with Acute Pancreatitis. Case Reports in Endocrinology 2018, pages 1-4.
Crossref

Kyung Ae LeeHeung Yong JinNa Young LeeYu Ji KimTae Sun Park. (2018) Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats. Diabetes & Metabolism Journal 42:4, pages 338.
Crossref

Krit Jaikumkao, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn C. Chattipakorn, Nipon Chattipakorn & Anusorn Lungkaphin. (2017) The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes. Biomedicine & Pharmacotherapy 94, pages 176-187.
Crossref

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date